Save Article

Electrical Heart Devices
Watch Their Sales Soar

By

Thomas M. BurtonStaff Reporter of The Wall Street Journal

Updated Sept. 23, 2002 8:07 p.m. ET

Electrical devices to treat heart failure have achieved one of the fastest sales takeoffs ever among medical devices, and new cardiology-practice guidelines coming out this week are expected to further boost marketing of the cardiac "resynchronization" machines.

In their first full year on the market, the devices from Medtronic Inc. of Minneapolis, Guidant Corp. of Indianapolis and St. Jude Medical Inc. of St. Paul, Minn., are expected to generate nearly $650 million in sales, according to some on Wall Street, up...